US 11396647
Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy
granted A61KA61K2039/505A61K38/45
Quick answer
US patent 11396647 (Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy) held by The Board of Regents of the University of Texas System expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K38/45, A61K39/395, A61K45/06